Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 66

Sort by

Sort Order Select

Journal Articles

Exploring Prognostic Factors of Venetoclax Combined with Azacitidine in Unfit AML Based on Real-World Data from a Chinese Population

Boyue Zheng, FU JIyi, Jiafei Wu, Wang Yu, Jun Wang, Chuanyan Jiang, Wang Huan, Yang Haiqing, Xi Yang, Hong Zheng, Li Hui

Blood (2024) 144 (Supplement 1): 5948.

https://doi.org/10.1182/blood-2024-205623

Published: 2024

Journal Articles

Venetoclax Plus Chidamide/Azacitidine Dual Epigenetic Target Regimen in High-Risk Acute Lymphoblastic Leukemia: Preclinical and Case Series Studies

Boyue Zheng, FU JIyi, Wang Yijing, Wang Yu, Wang Huan, Yang Haiqing, Yang XI, Hong Zheng, Li Hui

Blood (2024) 144 (Supplement 1): 5894.

https://doi.org/10.1182/blood-2024-202512

Published: 2024

Journal Articles

Efficacy and Safety of Dose-Tailored Mitoxantrone Liposomes Combined with Cytarabine and Venetoclax in Newly Diagnosed Acute Myeloid Leukemia (Non-M3) Based on Marrow Leukemic Cellularity

Li Hui, FU JIyi, Boyue Zheng, Lianjie HU, Yaqiong LI, Xin WANG, Qing HU, Li Wei, Hai Yi, Ying Yuan, Wang Huan, Yang Haiqing, Xi Yang, Hong Zheng, Yongqian Jia

Blood (2024) 144 (Supplement 1): 6068.

https://doi.org/10.1182/blood-2024-203401

Published: 2024

Journal Articles

Human IFN-α2- and PD-L1-Modified T Cells (αp-T cells) Inhibit Graft-Versus-Host Disease but Retain Anti-Leukemia Activity

Yuanyuan Tian, Bei Jia, Che Young Lee, Qingrong Huang, Chenchen Zhao, Ciril Abraham, Wenbin Mo, Mimi Chen, Ying WANG, Hong Zheng, Yi Zhang

Blood (2024) 144 (Supplement 1): 87.

https://doi.org/10.1182/blood-2024-203954

Published: 2024

Journal Articles

Risk Factors for CMV Infection, Including HLA Disparity and Ptcy Transplant in the Era of Letermovir Prophylaxis

Blood (2023) 142 (Supplement 1): 4914.

https://doi.org/10.1182/blood-2023-187917

Published: 2023

Journal Articles

Older Adults with Acute Myeloid Leukemia (AML) Experience Improvement in Health-Related Quality of Life (HRQoL) Scores with Intensive Therapy: Prospective Study from ECOG-ACRIN (EA) E2906 Phase 3 Trial

Blood (2023) 142 (Supplement 1): 594.

https://doi.org/10.1182/blood-2023-189734

Published: 2023

Journal Articles

Sting-Mediated Interferon Signaling Exerts Potent Antileukemic Effects in High-Risk Myeloid and Monocytic Malignancies

Yue Wei, Ziyi Li, Hui Yang, Hong Zheng, Vicky Appleman, Tiquella Hatten, Yu-Chung Huang, Jeffrey Raizer, Alex Parent, Neil Lineberry, Guillermo Garcia-Manero, Guillermo Montalban-Bravo

Blood (2023) 142 (Supplement 1): 3212.

https://doi.org/10.1182/blood-2023-177985

Published: 2023

Journal Articles

Downregulation of UBA1 in Myelodysplastic Syndrome

Yue Wei, Rashmi Kanagal-Shamanna, Hong Zheng, Pamela Lockyer, Faezeh Darbaniyan, Ziyi Li, Kim-Anh Do, Guillermo Garcia-Manero

Blood (2022) 140 (Supplement 1): 6884–6885.

https://doi.org/10.1182/blood-2022-158297

Published: 2022

Journal Articles

Single Center Experience of " Mobilize，Collect and Transplant, No Cryopreservation" Integrated Autologous Hematopoietic Stem Cells Transplantation Strategy for Newly Diagnosed Multiple Myeloma

Xi Yang, Chenglong Li, Feifei Che, Hong Zheng, Jiao Chen, Xiaobing Huang

Blood (2022) 140 (Supplement 1): 12930.

https://doi.org/10.1182/blood-2022-168915

Published: 2022

Journal Articles

Data of Daratumumab from a Real-World Single-Center Study

Jun Wang, Jiafei Wu, Xi Yang, Hong Zheng, Yijing Wang, Boyue Zheng, Feiyang Li, Hui Li

Blood (2022) 140 (Supplement 1): 12650.

https://doi.org/10.1182/blood-2022-170588

Published: 2022

Journal Articles

Viridans Group Streptococcal Bacteremia after Allogeneic Stem Cell Transplant with Post-Transplant Cyclophosphamide

Blood (2022) 140 (Supplement 1): 7589–7590.

https://doi.org/10.1182/blood-2022-167227

Published: 2022

Journal Articles

Leonurine Promotes the Maturation of Healthy Donors and Multiple Myeloma Patients Derived-Dendritic Cells

Cheng Chen, Lin He, Xi Wang, Zichen Ye, Rong Xiao, Hong Zheng, Shu Chen, Hui Li, Xi Yang, Xuemei Wang, Yu Wang, Xuemei Ye, Xiaobing Huang, Jingying Dai

Blood (2022) 140 (Supplement 1): 12439.

https://doi.org/10.1182/blood-2022-157665

Published: 2022

Journal Articles

Engraftment Kinetics and Recipient Chimerism Increase to Predict Leukemia Relapse By Ptcy and Non-Ptcy Transplant

Ruoheng Zhang, Kevin L Rakszawski, Myles Nickolich, W. Christopher Ehmann, Baldeep Wirk, Seema G Naik, Witold B. Rybka, Hong Zheng, Joseph Mierski, Brooke Silar, Gina Mackey, Jason Liao, Shouhao Zhou, Robert Greiner, Valerie Brown, David F. Claxton, Shin Mineishi, Hiroko Shike, Kentaro Minagawa

Blood (2021) 138 (Supplement 1): 1792.

https://doi.org/10.1182/blood-2021-148872

Published: 2021

Journal Articles

High-Dose Intravenous Acyclovir Is Safe and Effective in the Treatment of EBV Reactivation Post Allogeneic Hematopoietic Stem Cell Transplantation

Yu Wang, Xuemei Ye, Hong Zheng, Yan Mao, Xuemei Wang, Feifei Che, Chunsen Wang, Xi Yang, Xiaobing Huang

Blood (2021) 138 (Supplement 1): 4863.

https://doi.org/10.1182/blood-2021-149569

Published: 2021

Journal Articles

Pomalidomide Promotes the Maturation of Healthy Donors and Multiple Myeloma Patients Derived-Dendritic Cells

Xi Wang, Feifei Che, Wanjun Cao, Zichen Ye, Hong Zheng, Xiaobing Huang, Rong Xiao, Wen Wang, Xuemei Ye, Lin He, Jingying Dai

Blood (2021) 138 (Supplement 1): 4702.

https://doi.org/10.1182/blood-2021-146768

Published: 2021

Journal Articles

Inhibition of MDM2 Improves the Therapeutic Effect of Hypomethylating Agents in Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML)

Yue Wei, Hong Zheng, Pamela Lockyer, Naran Bao, Faezeh Darbaniyan, Ziyi Li, Rashmi Kanagal-Shamanna, Kelly A. Soltysiak, Hui Yang, Irene Ganan-Gomez, Kim-Anh Do, Simona Colla, Kelly S. Chien, Guillermo Montalban-Bravo, Naval Daver, Guillermo Garcia-Manero

Blood (2021) 138 (Supplement 1): 3664.

https://doi.org/10.1182/blood-2021-150811

Published: 2021

Journal Articles

Dasatinib Promotes the Maturation of Healthy Donors and Chronic Myelogenous Leukemia Patients Derived Dendritic Cells

Wangjun Cao, Lin He, Hong Zheng, MDPhD, Xiaobing Huang, Xi Yang, Xiaodong WANG, MD, Jingying Dai, PhD

Blood (2020) 136 (Supplement 1): 53–54.

https://doi.org/10.1182/blood-2020-138462

Published: 2020

Journal Articles

Long-Term Follow-up of Hematopoietic Stem Cell Transplantation with the Modified Peking Regimen for the Treatment of Acute Leukemia

Xi Yang, Chenglong Li, MDand PhD, Rong Zhang, MDand PhD, Hong Zheng, MD PhD, Qing Wei, MD PhD, Chunsen Wang, MD, Jingying Dai, PhD, Xiaobing Huang, Ningning Tang

Blood (2019) 134 (Supplement_1): 2034.

https://doi.org/10.1182/blood-2019-124419

Published: 2019

Journal Articles

Dose-Adjusted Granulocyte Colony-Stimulating Factor Plus Dexamethasone Achieves More CD34+ Cell Mobilization and Earlier Engraftment in Haploidentical Hematopoietic Stem Cell Transplantation

Chenglong Li, MDand PhD, Xi Yang, Jingying Dai, PhD, Ningning Tang, Hong Zheng, MD PhD, Chunsen Wang, MD, Xiaobing Huang

Blood (2019) 134 (Supplement_1): 1966.

https://doi.org/10.1182/blood-2019-126632

Published: 2019

Journal Articles

KDM6B Overexpression and TET2 Deficiency Cooperatively Drive Development of Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia-like Phenotype in Mice

Yue Wei, PhD, Hong Zheng, Naran Bao, Rashmi Kanagal-Shamanna, MD, Caleb Class, PhD, Hui Yang, PhDMD, Guillermo Montalban Bravo, MD, Irene Ganan-Gomez, PhD, Kelly Soltysiak, PhD, Kim-Ann Do, Simona Colla, PhD, Carlos E. Bueso-Ramos, MD PhD, Guillermo Garcia-Manero, MD

Blood (2019) 134 (Supplement_1): 562.

https://doi.org/10.1182/blood-2019-122574

Published: 2019

NARROW

Exploring Prognostic Factors of Venetoclax Combined with Azacitidine in Unfit AML Based on Real-World Data from a Chinese Population

Venetoclax Plus Chidamide/Azacitidine Dual Epigenetic Target Regimen in High-Risk Acute Lymphoblastic Leukemia: Preclinical and Case Series Studies

Efficacy and Safety of Dose-Tailored Mitoxantrone Liposomes Combined with Cytarabine and Venetoclax in Newly Diagnosed Acute Myeloid Leukemia (Non-M3) Based on Marrow Leukemic Cellularity

Human IFN-α2- and PD-L1-Modified T Cells (αp-T cells) Inhibit Graft-Versus-Host Disease but Retain Anti-Leukemia Activity

Risk Factors for CMV Infection, Including HLA Disparity and Ptcy Transplant in the Era of Letermovir Prophylaxis

Older Adults with Acute Myeloid Leukemia (AML) Experience Improvement in Health-Related Quality of Life (HRQoL) Scores with Intensive Therapy: Prospective Study from ECOG-ACRIN (EA) E2906 Phase 3 Trial

Sting-Mediated Interferon Signaling Exerts Potent Antileukemic Effects in High-Risk Myeloid and Monocytic Malignancies

Downregulation of UBA1 in Myelodysplastic Syndrome

Single Center Experience of " Mobilize，Collect and Transplant, No Cryopreservation" Integrated Autologous Hematopoietic Stem Cells Transplantation Strategy for Newly Diagnosed Multiple Myeloma

Data of Daratumumab from a Real-World Single-Center Study

Viridans Group Streptococcal Bacteremia after Allogeneic Stem Cell Transplant with Post-Transplant Cyclophosphamide

Leonurine Promotes the Maturation of Healthy Donors and Multiple Myeloma Patients Derived-Dendritic Cells

Engraftment Kinetics and Recipient Chimerism Increase to Predict Leukemia Relapse By Ptcy and Non-Ptcy Transplant

High-Dose Intravenous Acyclovir Is Safe and Effective in the Treatment of EBV Reactivation Post Allogeneic Hematopoietic Stem Cell Transplantation

Pomalidomide Promotes the Maturation of Healthy Donors and Multiple Myeloma Patients Derived-Dendritic Cells

Inhibition of MDM2 Improves the Therapeutic Effect of Hypomethylating Agents in Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML)

Dasatinib Promotes the Maturation of Healthy Donors and Chronic Myelogenous Leukemia Patients Derived Dendritic Cells

Long-Term Follow-up of Hematopoietic Stem Cell Transplantation with the Modified Peking Regimen for the Treatment of Acute Leukemia

Dose-Adjusted Granulocyte Colony-Stimulating Factor Plus Dexamethasone Achieves More CD34+ Cell Mobilization and Earlier Engraftment in Haploidentical Hematopoietic Stem Cell Transplantation

KDM6B Overexpression and TET2 Deficiency Cooperatively Drive Development of Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia-like Phenotype in Mice

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only